Akebia Therapeutics, Inc. (AKBA)
0.865
-0.01
(-0.69%)
USD |
NASDAQ |
Oct 02, 16:00
0.85
-0.02
(-1.73%)
After-Hours: 20:00
Akebia Therapeutics Price : 0.865 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 0.888 | 0.8885 | 0.84 | 0.865 | 7.105M |
| Oct 01, 2026 | 0.9149 | 0.9199 | 0.868 | 0.871 | 4.518M |
| Sep 30, 2026 | 0.8939 | 0.9311 | 0.866 | 0.92 | 10.83M |
| Sep 29, 2026 | 0.8996 | 0.90 | 0.87 | 0.8861 | 3.454M |
| Sep 28, 2026 | 0.8863 | 0.8999 | 0.875 | 0.8931 | 3.399M |
| Sep 25, 2026 | 0.9211 | 0.9269 | 0.8929 | 0.8962 | 4.378M |
| Sep 24, 2026 | 0.92 | 0.9482 | 0.9104 | 0.919 | 3.730M |
| Sep 23, 2026 | 0.987 | 0.987 | 0.93 | 0.9326 | 5.391M |
| Sep 22, 2026 | 0.95 | 1.00 | 0.9395 | 0.98 | 5.111M |
| Sep 21, 2026 | 0.927 | 0.946 | 0.9178 | 0.9385 | 11.09M |
| Sep 18, 2026 | 0.89 | 0.9266 | 0.88 | 0.9157 | 7.373M |
| Sep 17, 2026 | 0.9256 | 0.9401 | 0.8702 | 0.8955 | 8.717M |
| Sep 16, 2026 | 0.9082 | 0.9362 | 0.8952 | 0.9178 | 7.504M |
| Sep 15, 2026 | 0.9617 | 0.977 | 0.9026 | 0.903 | 5.779M |
| Sep 14, 2026 | 0.952 | 1.02 | 0.9026 | 0.9629 | 8.833M |
| Sep 11, 2026 | 0.97 | 0.9828 | 0.9512 | 0.9517 | 6.141M |
| Sep 10, 2026 | 0.95 | 0.9677 | 0.9312 | 0.9465 | 4.922M |
| Sep 09, 2026 | 1.03 | 1.049 | 0.95 | 0.9539 | 4.880M |
| Sep 08, 2026 | 0.9616 | 1.03 | 0.9528 | 1.03 | 3.065M |
| Sep 04, 2026 | 0.988 | 0.9961 | 0.9471 | 0.9747 | 8.348M |
| Sep 03, 2026 | 0.9999 | 1.00 | 0.9615 | 0.9833 | 7.457M |
| Sep 02, 2026 | 0.95 | 1.01 | 0.9474 | 0.9803 | 12.86M |
| Sep 01, 2026 | 0.9099 | 0.9472 | 0.9099 | 0.9447 | 12.45M |
| Aug 31, 2026 | 0.88 | 0.9349 | 0.855 | 0.9188 | 15.18M |
| Aug 28, 2026 | 0.935 | 0.94 | 0.865 | 0.8786 | 10.19M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Emergent BioSolutions, Inc. | 6.33 |
| Exelixis, Inc. | 58.39 |
| ADMA Biologics, Inc. | 9.72 |
| Arcutis Biotherapeutics, Inc. | 25.16 |
| Relay Therapeutics, Inc. | 18.96 |
Price Related Metrics
| PS Ratio | 1.063 |
| Price to Book Value | 9.395 |
| Price to Free Cash Flow | 5.781 |
| Earnings Yield | -12.83% |
| Market Cap | 235.06M |